DR. AGARWAL'S EYE HOSP L vs TORRENT PHARMACEUTICALS L
A side-by-side comparison of DR. AGARWAL'S EYE HOSP L (DRAGARWQ) and TORRENT PHARMACEUTICALS L (TORNTPHARM) — valuation, profitability, growth, and financial health — to help you judge which is the stronger buy today.
DR. AGARWAL'S EYE HOSP L vs TORRENT PHARMACEUTICALS L are evenly matched on the numbers (7–7). The breakdown below shows where each one wins.
- Valuation31
- Profitability13
- Growth20
- Size & financial health13
Each axis shows this group's split of that metric, scaled so the leader sits at the edge. Relative to each other, not an absolute score.
Valuation
DRAGARWQ takes 3/4How expensive each stock is relative to its earnings and book value. Lower usually means cheaper.
Profitability
TORNTPHARM takes 3/4How efficiently each company turns capital and sales into profit. Higher is better.
Growth
DRAGARWQ takes 2/2Three-year compounded growth. Faster-growing businesses can justify a higher valuation.
Size & financial health
TORNTPHARM takes 3/4Scale and balance-sheet strength. Bigger revenue/profit and lower debt are generally safer.
- + ["Company has delivered good profit growth of 120% CAGR over last 5 years", "Company has a good return on equity (ROE) track record: 3 Years ROE 28.6%"]
- − ["Stock is trading at 7.32 times its book value", "Company might be capitalizing the interest cost"]
- + ["Company is expected to give good quarter", "Company has a good return on equity (ROE) track record: 3 Years ROE 26.2%", "Company has been maintaining a healthy dividend payout of 57.8%"]
- − ["Stock is trading at 20.4 times its book value", "Promoter holding has decreased over last quarter: -7.53%", "The company has delivered a poor sales growth of 11.8% over past five years.", "Company might be capitalizing the interest cost"]
This comparison is for informational purposes only and is not investment advice. Please consult a SEBI-registered advisor before investing.